Canada’s batch of AstraZeneca vaccines considered safe amidst reports of blood clots

Denmark has temporarily suspended the use of the AstraZeneca vaccine after reports of blood clots in some people, but its health authority said Thursday it has no evidence the vaccine was responsible.

Other experts pointed out that of the millions of AstraZeneca vaccine shots administered elsewhere, including in Britain, there have been no reported cases of the vaccine causing blood clots or related problems.

On Thursday, AstraZeneca Canada confirmed to 680 NEWS the batch of doses the country has secured are different than the ones being investigated for the aforementioned side effects.

“We’re aware of the statement made today by Sundhedsstyrelsen (the Danish Health Authority) that they are currently investigating potential adverse events related to vaccination against COVID-19,” an AstraZeneca Canada spokesperson said in an email.

“Patient Safety is the highest priority for AstraZeneca. Regulators have clear and stringent efficacy and safety standards for the approval of any new medicine, and that includes AstraZeneca COVID-19 Vaccine.”

Health Canada has recommended that the shot be administered to people aged 60 to 64.

“The safety of the vaccine has been extensively studied in Phase 3 clinical trials and Peer-reviewed data confirms the vaccine has been generally well-tolerated,” AstraZeneca Canada said. 

“We immediately shared this global information with Health Canada and will continue to share evolving data on our vaccine from both Canada and around the world as part of our ongoing pharmaco-vigilance activities.”

Denmark’s Health Authority said its decision was “based on a precautionary principle” and that one person who developed a blood clot after vaccination had died.

“At present, it cannot be concluded whether there is a link between the vaccine and the blood clots,” authorities said. Danish officials did not say whether the patient had any underlying conditions and did not provide any other details.

In a statement on Thursday, the European Medicines Agency said “the vaccine’s benefits continue to outweigh its risks and the vaccine can continue to be administered” while a closer evaluation of the blood clot cases continues.

“There is currently no indication that vaccination has caused these conditions,” the regulator said.

RELATED: Ontario pharmacies to begin administering AstraZeneca vaccine to those aged 60-64


It said the number of people with blood clots in vaccinated people was no higher than those who hadn’t been inoculated.

Some doctors pointed out that people now being immunized against COVID-19 are more likely to already have health problems and that it would be difficult to determine whether a vaccine shot is responsible.

“The vast majority of people being vaccinated at the moment are elderly or have got underlying diseases,” said Dr. Paul Hunter, a professor of medicine at the University of East Anglia. “They will be at increased risk for all sorts of adverse outcomes, regardless of whether or not they have been vaccinated.”

Hunter said there were 11 reports of blood clots in Britain among the more than 11 million people given the AstraZeneca vaccine, and none have been shown to have been caused by the shot. He said pausing immunizations was also a risky decision in itself.

“When you stop vaccinating, you know that some people will die of COVID-19,” he said.

Denmark’s suspension of the AstraZeneca vaccine will last for at least two weeks, the agency said, adding it hinged on an evaluation by the EU medical regulator.

“Like others, I find (the pausing) and its consequences annoying. It’s too early to conclude in this case and when there is a risk, it must be investigated,” Danish Prime Minister Mette Frederiksen said.

In Ontario, Health Minister Christine Elliott addressed these concerns, saying the province will continue rolling out the vaccine across pharmacies.

“AstraZeneca has been approved by Health Canada for both safety and efficacy,” said Elliott.

“We don’t have any plans to discontinue AstraZeneca at this time. However, we will be following the investigation and working with Health Canada to determine if any changes need to be made in Ontario’s plan.”

“We are continuing with our AstraZeneca inoculations and we know that several million doses [of different vaccines] have already been administered,” she added.

Dr. Zain Chagla, an infectious disease doctor at St. Joseph’s Hospital in Hamilton, says that Health Canada is constantly reviewing data on vaccines and it is a normal part of the post-approval process to see these types of investigations occur.

He says he will give the vaccine as planned to his patients unless Health Canada changes its current decision that the benefits of the vaccine outweigh the risks.

Canada’s first 500,000 doses of the AstraZeneca vaccine arrived in provinces this week, but they were made in India, not in the same European facilities where the doses in question were produced.

Norway, Italy temporarily pause AstraZeneca distribution

After the Danish announcement, Norway decided to follow suit and temporarily suspend the Anglo-Swedish company’s vaccine, which was developed by the University of Oxford, also saying that there are no proven links.

In addition, Italy’s pharmaceutical agency on Thursday ordered a precautionary ban on a particular batch of the AstraZeneca vaccine after what it said were “serious adverse events.”

In an interview with the broadcaster La Sexta, Spanish Health Minister Carolina Darias said there had been no similar incidents in Spain and said only minor side effects had been reported from the AstraZeneca vaccine.


RELATED: Trudeau says Johnson & Johnson shipments could be delayed due to manufacturing problems


Dr. Bharat Pankhania, an infectious diseases expert at Britain’s University of Exeter, called Denmark’s decision to pause its use of AstraZeneca shots “a dramatic step.”

“The vaccine has been given to several million people all over the world and we have not had similar reports of vaccine-induced clotting,” he said, adding that the blood clots were more likely to be “separate, unconnected events.”

Britain’s medicines regulator reacted by noting there was no confirmation that the reported blood clot was caused by the AstraZeneca vaccine. “People should still go and get their COVID-19 vaccine when asked to do so,” it said.

But Hendrik Streeck, a German virologist at the University of Bonn, said the Danish decision was the right one.

“It’s not clear what the cause was, that’s why the vaccinations are being stopped for now,” Streeck told German broadcaster n-tv. “In very rare cases, there can be a problem with a specific batch. Now they are looking to see what caused the clot.”

“We don’t want to put anybody at risk, but I’m not concerned,” he said. “The exact right thing is being done in Denmark.”

On Wednesday, the EMA said Austria had suspended the use of a batch of COVID-19 vaccine made by AstraZeneca after a person had been diagnosed with multiple blood clots died 10 days after vaccination, and another was hospitalized with a blockage in arteries in the lungs after being vaccinated.

The latter is now recovering.


With files from The Associated Press, The Canadian Press, and 680 NEWS Parliament Hill reporter Cormac Mac Sweeney

Top Stories

Top Stories

Most Watched Today